;

Articles Not Curated - Diagnostics
Last updated: 2024 Oct 18
Total hit(s): 27933
S.No.
1
39319285
Regional variations in HIV diagnosis in Japan before and during the COVID-19 pandemic.
Infect Dis Model
2025 Mar
- n/a -
1
2
39550107
Interventions to Improve COVID-19 Vaccine Hesitancy.
Rheum Dis Clin North Am
2025 Feb
1
3
39550104
The Short and Long of COVID-19: A Review of Acute and Chronic Radiologic Pulmonary Manifestations of SARS-2-CoV and Their Clinical Significance.
Rheum Dis Clin North Am
2025 Feb
1
4
39182703
Diosmetin-7-O-beta-D-glucopyranoside from Pogostemonis Herba alleviated SARS-CoV-2-induced pneumonia by reshaping macrophage polarization and limiting viral replication.
J Ethnopharmacol
2025 Jan 10
6.8
1
5
39277919
SARS-CoV-2 detection in COVID-19 patients' sample using Wooden quoit conformation structural aptamer (WQCSA)-Based electronic bio-sensing system.
Biosens Bioelectron
2025 Jan 1
9.52
1
6
39546228
Psycho-Neuro-EndocrinE-Immunology Therapy of Cancer, Autoimmunity, Geriatric Disorders, Covid-19, and Hypertension.
Methods Mol Biol
2025
10.71
1
7
38185645
Hyperferritinemia as a factor associated with poor prognosis in COVID-19 patients.
Ceska Slov Farm
2024 Winter
0.36
1
8
38195430
Hyperferritinemia as a factor associated with poor prognosis in COVID-19 patients.
Ceska Slov Farm
2024 Winter
0.36
1
9
38988848
Presumed Fourth Nerve Palsy in a Healthy and Asymptomatic Child with COVID-19 Infection.
Iran J Child Neurol
2024 Summer
1
10
38556935
Symptom Exacerbations of Patients Attending a Community Mental Health Center During the COVID-19 Pandemic.
Turk Psikiyatri Derg
2024 Spring
1
11
39359433
COVID-19 infection after vaccination.
Caspian J Intern Med
2024 Fall
1.36
1
12
39359451
COVID-19 associated lung cavitary lesions: A case series.
Caspian J Intern Med
2024 Fall
1.36
1
13
38622888
SARS-CoV-2 seroprevalence among healthcare workers in a highly vaccinated Japanese medical center from 2020-2023.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
14
39171541
Factors influencing antibody response after COVID-19 recombinant protein vaccination in adults: A cross-sectional observational study, in Chongqing, China.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
15
38832632
Vaccination status and disease severity of COVID-19 in different phases of the pandemic.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
16
38439670
An analysis of reported cases shoulder injury related to vaccine administration of after COVID-19 vaccination.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
17
39254005
Genomic insights into mRNA COVID-19 vaccines efficacy: Linking genetic polymorphisms to waning immunity.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
18
38860498
Lessons from community engagement to improve COVID-19 diagnosis and treatment in Cochabamba, Bolivia.
Glob Health Action
2024 Dec 31
1.91
1
19
38372198
Development of a quantitative ELISA for SARS-CoV-2 vaccine candidate, NDV-HXP-S, with CpG 1018(R) adjuvant.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
20
38361363
Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
21
38374618
A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
22
39056147
Effectiveness of AstraZeneca vaccine against SARS-CoV-2 (ChAdox1-S) in reducing in-hospital mortality in individuals with COVID-19 and schizophrenia: A retrospective cohort study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
23
38191194
Enhanced immunity against SARS-CoV-2 in returning Chinese individuals.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
24
39051458
Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
25
38317419
Allergy to PEG (polyethylene glycol) - sensitivity of basophil activation test with COVID-19 mRNA-vaccine BNT162B2.
Hum Vaccin Immunother
2024 Dec 31
4.7
1